TREA

90858291 - COHERUS

Follow

Information

  • Trademark
  • 90858291
  • Serial Number
    90858291
  • Registration Number
    6921362
  • Filing Date
    July 30, 2021
    3 years ago
  • Registration Date
    December 13, 2022
    2 years ago
  • Transaction Date
    May 17, 2024
    8 months ago
  • Status Date
    December 13, 2022
    2 years ago
  • Published for Opposition Date
    September 27, 2022
    2 years ago
  • Location Date
    December 13, 2022
    2 years ago
  • First Use Anywhere Date
    January 13, 2019
    6 years ago
  • First Use In Commerce Date
    January 13, 2019
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FATHY, DOMINIC
  • Attorney Name
    Perry J. Viscounty
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4
Mark Identification
COHERUS
Case File Statements
  • GS0051: pharmaceuticals for human immune diseases and conditions; pharmaceuticals for use in stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation; Pharmaceuticals for the treatment of cancer, autoimmune diseases, metabolic diseases, or ophthalmic diseases and conditions; Pharmaceutical preparations for the prevention and treatment of auto-immune, inflammatory, hematological, hepatological, cardiovascular, pulmonary, central nervous system, neurological system, pain, inflammation, dermatologic, gastro-intestinal, hormonal, psychiatric, infectious-related, viral, metabolic, oncologic, ophthalmic, respiratory, digital ulcers, musculo-skeletal, genitourinary, sexual dysfunction, and cerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives; pharmaceutical preparations for treatment of ocular diseases and disorders; pharmaceuticals for the treatment of oncology, immunology, ophthalmology diseases and disorders
  • GS0441: providing information in the fields of health and medicine; consulting services in the field of pharmaceuticals and medical care
  • GS0421: research, development and consulting services in the pharmaceutical research and biotechnology fields; consulting, research and development in the medical field
Case File Event Statements
  • 2/22/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/3/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/27/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/23/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/22/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/22/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/22/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/22/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/22/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/7/2022 - 2 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/24/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/27/2022 - 2 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/27/2022 - 2 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/13/2022 - 2 years ago
    15 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/16/2024 - 8 months ago
    16 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 12/13/2022 - 2 years ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR